期刊文献+

NDV诱导肿瘤疫苗的制备及其在肿瘤主动免疫治疗中的应用 被引量:2

Preparation of Tumor Cell vaccine induced by Newcastle disease virus and Preliminary Study on active immunity of autogenous tumor cell vaccine after operation of carcinoma
下载PDF
导出
摘要 目的:探讨新城鸡瘟病毒 (NDV )修饰的自体肿瘤细胞疫苗 (ATV - NDV)的作用机制及临床意义。 方法 :用 NDV对自体肿瘤细胞进行活化、修饰、灭活后制备成肿瘤疫苗 ,用 EL ISA法对 5 2例肿瘤患者手术前后及免疫接种后外周血清中的 SIL- 2、IL- 2 R、IL- 6和 TNF进行检测 ,并与正常对照组进行比较。 结果:5 2例肿瘤患者IL- 2 R、IL- 6、TNF水平明显高于正常对照组 (P <0 .0 1) ,而 SIL- 2水平明显降低 (P <0 .0 1)。患者手术后 IL- 2 R、IL- 6较手术前明显增高 (P <0 .0 1) ,SIL- 2、TNF较手术前有所降低 (P >0 .0 5 )。经免疫接种 ,患者 SIL- 2较接种前明显增高 (P <0 .0 1) ,而 IL- 2 R、IL- 6、TNF较接种前明显降低 (P <0 .0 1)。 结论 :经 NDV修饰的 ATV- NDV是一种免疫源性高和安全有效的免疫制剂 ,具有针对性强、特异性高的优点 。 Objective: To evaluate the anti tumer machanism and clinical significance of Newcastle Disease Virus modified autologous tumor cell vaccine (ATV NDV). Methods: The serum level of SIL 2、IL 2R、IL 6 and TNF expressions were detected with ELISA from 52 cases of tumor patients which were active immunotherapy by ATV NDV in pre operation、post operation and after immunization espectively. Results: In pre operation, the serum level of IL 2R、IL 6 and TNF were higher than the control group, but SIL 2 lower than that. In the fourteenth day after surgery the serum levels of IL 2R、IL 6 increased significantly while SIL 2、TNF were no significant differences. After immunization, the serum level of SIL 2 increased significantly, but IL 2R、IL 6 and TNF decreased significantly than before immunization. Conclusion: ATV NDV was a safe, effective and high specially immune pharmaceutics。 It can improve the patient anti tumor immune response
出处 《新疆医科大学学报》 CAS 2004年第2期135-137,共3页 Journal of Xinjiang Medical University
基金 新疆维吾尔自治区自然科学基金项目资助 (9980 6)
关键词 新城鸡瘟病毒 免疫源性 自体肿瘤细胞疫苗 NDV 肿瘤主动免疫治疗 Newcastle disease virus induced Tumor vaccine immunogenicity autologous tumor cell vaccine
  • 相关文献

参考文献11

  • 1曲增强,吴孟超,陈汉,张晓华.新城疫病毒瘤苗对荷瘤小鼠的主动免疫治疗作用[J].实用癌症杂志,1996,11(2):73-75. 被引量:8
  • 2Kugler A, Stuhler G, Walden P, et al. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dentritic cell hybirds[J]. Nat Med, 2000, 6:332-336.
  • 3Rains N, Cannan RJ, Chen W, et al, Development of a dendritic cell (DC)-based vaccine for patients with advanced colorectal cancer[J]. Hepatogastroenterology, 2001,48:347-351.
  • 4Todrk SM, Birchall LJ, Erlich R, et al. Efficacy of cytokine gene transfection may differ for autologousandallogeneic tumor cell vaccines[J]. Immunology ,2001,102 : 190-198.
  • 5Ockert D, Schirrmacher V, Beck N, et al. Newcastle Disease Virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma[J]. Clin cancer Res,1996,2:21-28.
  • 6Ahlert T, Sauerbrei W, Bastert G, et al. Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast orovarian cancer[J]. J Clin Oncol, 1997,15 : 1354-1366.
  • 7Ockert D, Schirrmacher V, Beck N, et al. Newcastle Disease Virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma[J]. Clin cancer Res, 1996,2 : 21-28.
  • 8Ahlert T, Sauerbrei W, Bastert G, et al. Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer[J]. J Clin Oncol, 1997,15:1354-1366.
  • 9Kugler A, Stuhler G, Walden P, et al. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dentritic cell hybirds[J]. Nat Med, 2000, 6:332-336.
  • 10Rains N, Cannan RJ, Chen W, et al. Development of a dendritic cell (DC)-based vaccine for patients with advanced colorectal cancer[J]. Hepatogastroenterology, 2001,48 : 347-351.

共引文献7

同被引文献12

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部